Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus
Karan Govindpani, Clinton Turner, Henry J. Waldvogel, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8704-8704
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Neurotransmitters—Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System
Raluca Ioana Teleanu, Adelina-Gabriela Niculescu, Eugenia Roza, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5954-5954
Open Access | Times Cited: 257
GABAA receptors: structure, function, pharmacology, and related disorders
Amr Ghit, Dina Assal, Ahmed S. Al‐Shami, et al.
Journal of Genetic Engineering and Biotechnology (2021) Vol. 19, Iss. 1, pp. 123-123
Open Access | Times Cited: 248
Probiotics for Alzheimer’s Disease: A Systematic Review
Ruth Naomi, Hashim Embong, Fezah Othman, et al.
Nutrients (2021) Vol. 14, Iss. 1, pp. 20-20
Open Access | Times Cited: 110
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Shaochang Wu, Xia Liu, Ruilai Jiang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 105
Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
S. Meftah, Jian Gan
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 70
Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ali K. Albuhadily, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 16
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
Haiyang Du, Xiaoyu Meng, Yao Yu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 48
The GABAergic system in Alzheimer’s disease: a systematic review with meta-analysis
Giovanna Carello‐Collar, Bruna Bellaver, Pâmela C.L. Ferreira, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 5025-5036
Closed Access | Times Cited: 31
The hippocampus associated GABAergic neural network impairment in early-stage of Alzheimer's disease
Yuanhong Tang, Yan Yan, Jian Mao, et al.
Ageing Research Reviews (2023) Vol. 86, pp. 101865-101865
Closed Access | Times Cited: 22
Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit
Bandar Alharbi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 14
Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer’s disease
Kathryn A Conn, Emily M. Borsom, Emily K. Cope
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 14
Latest advances in mechanisms of epileptic activity in Alzheimer’s disease and dementia with Lewy Bodies
Mariane C. Vicente, Kwaku Addo-Osafo, Keith Vossel
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 12
Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer’s disease and 5XFAD mice
Aaron J Barbour, Sarah Gourmaud, Eunjoo Lancaster, et al.
Brain (2024) Vol. 147, Iss. 6, pp. 2169-2184
Closed Access | Times Cited: 11
Impairments of GABAergic transmission in hippocampus mediate increased susceptibility of epilepsy in the early stage of Alzheimer’s disease
Rui Mao, Mengsha Hu, Xuan Liu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Role of microbiota-gut-brain axis in Alzheimer's disease and possible interventions
Rohini Pujari, Shreya Sharma, Shvetank Bhatt
Elsevier eBooks (2025), pp. 19-41
Closed Access | Times Cited: 1
CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model
Lei Wan, Ping Zhong, Pei Li, et al.
Neurobiology of Disease (2025) Vol. 206, pp. 106826-106826
Open Access | Times Cited: 1
Identification of potential blood biomarkers associated with suicide in major depressive disorder
Firoza Mamdani, Matthieu D Weber, Blynn G. Bunney, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 35
Alzheimer’s disease large-scale gene expression portrait identifies exercise as the top theoretical treatment
Mason A. Hill, Stephen C. Gammie
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Sensory processing deficits and related cortical pathological changes in Alzheimer’s disease
Nicole K. Zhang, Selena K. Zhang, Li I. Zhang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 16
The underlying roles and neurobiological mechanisms of music-based intervention in Alzheimer's disease: A comprehensive review
Liyang Sun, Qin Wang, Jing Ai
Ageing Research Reviews (2024) Vol. 96, pp. 102265-102265
Closed Access | Times Cited: 6
Hippocampal circuit dysfunction in psychosis
Samuel Knight, Robert A. McCutcheon, Daniella Dwir, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
The fate of interneurons, GABAA receptor sub‐types and perineuronal nets in Alzheimer's disease
Afia B. Ali, Anam Islam, Andrew Constanti
Brain Pathology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 26
Unscrambling the cellular and molecular threads of Neuroplasticity: Insights into Alzheimer’s disease pathogenesis
Palak Kalra, Amarjot Kaur Grewal, Heena Khan, et al.
Neuroscience (2025)
Closed Access
Therapeutic Candidates for Alzheimer’s Disease: Saponins
Ruifeng Zhang, Miao Zeng, Xiaolu Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10505-10505
Open Access | Times Cited: 11
Changes in the Properties of Ethanol-Sensitive Molecular Targets During Maturation and Aging
Luis G. Aguayo, Lorena Armijo‐Weingart, Loreto San Martín, et al.
Advances in experimental medicine and biology (2025), pp. 299-316
Closed Access
Page 1 - Next Page

Scroll to top